Stock Analysis of Bluejay Diagnostics Inc (BJDX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code BJDX
Close 0.530
Change 0 / 0 %
Volume 13214.00
Vol Change 2323.00 / 21.33 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Low Growth Stock
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Bluejay Diagnostics Inc
PE (TTM)

-0.065

Very Poor
Price / Book

0.175

Excellent
Price / Sales

0.435

Excellent
Piotroski F Score

1.0

Very Poor
Market Cap

1539.36 K

Enterprise Value

-506167.50

ROA (TTM)

-179.39

Very Poor
ROE (TTM)

-273.28

Very Poor
Net Margin (TTM)

-672.24

Very Poor
Revenue

100.00 %

0
Net Profit

7.96 %

-10037.40 K
Debt to Equity

0.056

Excellent
Altman Z Score

-13.72

Very Poor
Quick Ratio

0

Poor
Cash Ratio

1.25

Indecisive


Highs/Lows of Bluejay Diagnostics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.49 8.16 % 0.513 % 0.550.4831-May-2430-May-24
Two Week0.58 8.62 % 0.486 % 0.590.407221-May-2422-May-24
One Month0.49 8.16 % 4.80 % 0.60.407217-May-2422-May-24
Three Month0.789 32.83 % 3.56 % 0.96680.3908-Mar-2430-Apr-24
Six Months3.23 83.59 % 15.54 % 3.910.3912-Dec-2330-Apr-24
One year4.726 88.79 % 26.26 % 13.97990.3924-Jul-2330-Apr-24
Two year21.4 97.52 % 27.72 % 17.60.3916-Feb-2330-Apr-24


Technical View of Bluejay Diagnostics Inc
RSI

47.14

Neutral
MACD

-0.0223

Bullish
ADX

33.47

Mild Bearish
Super Trend

0.676

Mild Bearish
Williams %R

-36.31

Neutral
CCI

-23.89

Neutral


EMA 5

0.521

Strong Bullish
EMA 15

0.526

Whipsaw
EMA 50

0.632

Strong Bearish
EMA 100

1.06

Mild Bearish
SMA 100

0.719

Mild Bearish
SMA 200

2.30

Mild Bearish
SMA 5 / 20

0.516 / 0.526

Strong Bearish
SMA 15 / 50

0.525 / 0.602

Mild Bearish
SMA 50 / 200

0.602 / 2.30

Mild Bearish




Charts of Bluejay Diagnostics Inc


Returns of Bluejay Diagnostics Inc with Peers
Period / StockBJDXSIENBBLGNMRDQLGN
1 Week8.16%-3.39%10.67%-3.00%-11.48%
1 Mth8.16%-69.37%6.31%-19.17%-9.94%
3 Mth-32.83%-77.11%-32.24%-36.27%-41.32%
6mth-83.59%-93.56%-49.27%-78.05%-61.98%
1 Year-88.79%-89.88%-95.92%-90.28%-70.74%
2 Year-97.52%-99.39%-99.56%-98.25%-95.19%
5 Years--99.83%-99.97%-99.46%-99.88%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Bluejay Diagnostics Inc with Peers
Ratio / StockBJDXSIENBBLGNMRDQLGN
PE-0.065-0.0208-0.117-0.162-0.076
P/B0.175-0.1270.189-0.1010.403
ROA-179.39-44.10-113.22-74.55-156.96
ROE-273.280-162.020-709.27
Debt To Equity0.05600-1.70-0.618
Revenue0
100.00 % 		90299.00 K
0.276 % 		0
% 		-1476.39 K
392.99 % 		4983.56 K
0 %
Net Income-10037.40 K
7.96 % 		-59123.00 K
19.80 % 		-6505.39 K
338.19 % 		-25104.74 K
80.78 % 		-17339.21 K
17.57 %


Technicals of Bluejay Diagnostics Inc with Peers
Technical / StockBJDXSIENBBLGNMRDQLGN-
ADX33.4722.8321.3628.1513.89
CMF0.094-0.628-0.361-0.337-0.0166
MFI42.7392.7564.4764.3543.66
RSI47.1427.8946.2548.5938.57
MACD Abv SignalTrueFalseFalseTrueTrue
Price Above 50 MAFalseFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalseFalse-


About : Bluejay Diagnostics Inc

Address : 360 Massachusetts Avenue, Acton, MA, United States, 01720
Tel : 844 327 7078
URL : https://www.bluejaydx.com
Code : BJDX, ISIN : US0956331039, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 10_Nov_2021
Employee Count : 10

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)